Qube Research & Technologies (QRT)’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
OP
Qube Research & Technologies (QRT)'s LYEL Position: Q3 2026 in Review
Qube Research & Technologies (QRT) increased its Lyell Immunopharma (LYEL) stake by 29% in Q3 2026, buying an estimated $424K and bringing the position to 142,401 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2477.
Qube Research & Technologies (QRT) first reported a position in LYEL in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.55M in Q2 2026. 105 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.
- Qube Research & Technologies (QRT) held 142,401 shares of Lyell Immunopharma worth $1.39M as of Q3 2026.
- Qube Research & Technologies (QRT) bought 31,870 Lyell Immunopharma shares in Q3 2026, an estimated $424K.
- Lyell Immunopharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2477 holding.
- Qube Research & Technologies (QRT) first reported a position in Lyell Immunopharma in Q2 2021 and has held it in 7 quarters since.
- Qube Research & Technologies (QRT)'s Lyell Immunopharma position peaked at $1.55M in Q2 2026.
- 105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.